NYSE
$345.00▼ 0.01%vs prev close
🔒 Quotes & buy pressure are MAX onlySee plans
Market cap $16.62BShares out 48.2M sh
Chart
Filings & news by date
Hover (PC) or tap (mobile) a candle to see that day only
Filings
28- 1d agoAfter-hours26.10.24 07:454Ownership#●●●
CHARLES RIVER LABORATORIES INTERNATIONAL, INC.
Shannon Parisotto, an executive at Charles River Laboratories, has filed a Power of Attorney to authorize designated attorneys-in-fact to handle SEC Section 16 filings. This is an administrative procedure to delegate the filing of required reports regarding her securities ownership and transactions.…more
$345.00-0.01%vs prev closeDetected5m · 30m · 60m · Next dayPLUSView filingShare
- 2d agoAfter-hours26.10.23 05:03144Ownership
CHARLES RIVER LABORATORIES INTERNATIONAL, INC.
James C. Foster of Charles River Laboratories International, Inc. (CRL) has filed an SEC Form 144 to report a proposed sale of company securities. This is a standard filing disclosing an insider's plan to dispose of shares.…more
$345.00-0.01%vs prev closeView filingShare - 3d agoAfter-hours26.10.22 05:05144Ownership
CHARLES RIVER LABORATORIES INTERNATIONAL, INC.
Shannon M. Parisotto, an executive at Charles River Laboratories International, Inc., has filed an SEC Form 144 to report a proposed sale of company shares. This filing serves as a formal notification of the executive's intent to dispose of their holdings.…more
$345.00-0.01%vs prev closeView filingShare
27 more filings
Sign up free to unlock the full feed and real-time filing & news alerts.
- ✓Free — no card required
- ✓Full real-time filing & news feed
- ✓Daily Today Report
News
GlobeNewswire- 2d agoAfter-hours26.10.23 05:36#●●●#●●●
Charles River Labs Partners with FDA and Labcorp to Develop Drug Abuse Assessment Tools…more
Charles River Laboratories has entered a research collaboration with the FDA and Labcorp to develop standardized tools for quantifying the abuse potential of new drugs. This initiative focuses on enhancing regulatory science and safety evaluation rather than immediate commercial revenue.…more
$345.00-0.01%vs prev closeDetected5m · 30m · 60m · Next dayPLUSShareBenzinga
- 10.13Pre-market26.10.13 21:04
●●●●●●●● ●●●●● ●●●●●●
Charles River Laboratories has entered a partnership with Magellan Stem Cells to support the development and clinical advancement of stem cell-based therapies. The collaboration will utilize Charles River's expertise in biologics quality control and testing to accelerate Magellan's regenerative medicine solutions.…more
$345.00-0.01%vs prev closeShareBenzinga - 10.6Pre-market26.10.06 21:13
●●●●●●●● ●●●●● ●●●●●●
Charles River Laboratories has launched 'Apollo Orchestrate' by integrating Autolomous's digital execution system to modernize laboratory workflows. This partnership aims to enhance automation and traceability across its North American and European biologics testing sites.…more
$345.00-0.01%vs prev closeShareBenzinga
2 more news items
Sign up free to unlock the full feed and real-time filing & news alerts.
- ✓Free — no card required
- ✓Full real-time filing & news feed
- ✓Daily Today Report